fibrinogen has been researched along with Venous Thrombosis in 207 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (3.86) | 18.7374 |
| 1990's | 10 (4.83) | 18.2507 |
| 2000's | 89 (43.00) | 29.6817 |
| 2010's | 70 (33.82) | 24.3611 |
| 2020's | 30 (14.49) | 2.80 |
| Authors | Studies |
|---|---|
| Franchini, S; Marcianò, T | 1 |
| Adelmeijer, J; Bernal, W; Blasi, A; de Haas, RJ; Driever, EG; Fondevila, C; Gregory, S; Heaton, N; Kane, P; Lisman, T; Nagasami, C; Porte, RJ; van den Heuvel, MC; von Meijenfeldt, FA; Weisel, JW; Zen, Y | 1 |
| Guo, J; Hou, Z; Long, Y; Wang, T; Yin, Y | 1 |
| Feng, Y; Lei, B; Li, X; Luo, X; Niu, L; Zhang, F; Zhang, H | 1 |
| He, S; Li, H; Liu, H; Qin, T; Xiao, L; Xu, WL; Zhang, T | 1 |
| Sang, Y; Wolberg, AS | 1 |
| Flick, MJ; Francisco, BJ; Mullins, ES; Owens, AP; Palumbo, J; Rosenfeldt, L; Russell, HM; Sharma, BK | 1 |
| Ge, JP; Gu, JP; He, J; Li, Y; Ma, K; Yin, YY | 1 |
| Adu, IK; Qi, G; Wu, H; Zheng, D; Zhu, M | 1 |
| Alfredsson, L; Askling, J; Bang, H; Cornillet, M; Grönwall, C; Hansson, M; Holmdahl, R; Kastbom, A; Klareskog, L; Lundberg, K; Mathsson-Alm, L; Rönnelid, J; Saevarsdottir, S; Serre, G; Skriner, K; Westerlind, H | 1 |
| Hwang, J; Hwang, SY; Kim, JH; Kim, MS; Koyanagi, A; Lee, MH; Lee, SB; Lee, SW; Park, SH; Shin, JI; Smith, L; Song, TJ; Tizaoui, K; Yon, DK | 1 |
| Chen, L; Chen, W; Liu, Q; Pan, Y; Peng, Z; Sha, Y; Wang, Y; Wang, Z | 1 |
| Şimşek, F; Yevgi, R | 1 |
| Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P | 1 |
| Asselta, R; Caccia, S; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Stasko, J; Zolkova, J | 1 |
| Benner, P; Betoule, A; Foucher, S; Gasperini, G; Martinet, C; Muller, P; Renard, A | 1 |
| Baron, RM; Chen, EC; Cheng, V; Cho, MH; Connell, NT; Connors, JM; Fredenburgh, LE; Moll, M; Sylvester, KW; Woolley, AE; Zon, RL | 1 |
| Cheng, J; Fu, Z; Song, W; Zhou, L; Zhu, J | 1 |
| Di Sanza, C; Fish, RJ; Freire, C; Grzegorski, SJ; Neerman-Arbez, M; Richter, CE; Shavit, JA; Vilar, R | 1 |
| Sharma, M; Surani, S | 1 |
| Di Sanza, C; Fish, RJ; Garieri, M; Lukowski, SW; Neerman-Arbez, M; Vilar, R | 1 |
| Pieters, M | 1 |
| Di Sanza, C; Fish, RJ; Freire, C; Neerman-Arbez, M | 1 |
| Chen, Y; Wen, H | 1 |
| Hu, FR; Pan, QY; Tao, HP; Wang, C; Zhao, X | 1 |
| Bikov, A; Meszaros, M; Schwarz, EI | 1 |
| Barrett, NA; Benedetti, G; Breen, KA; Camporota, L; Doyle, AJ; Hunt, BJ; Mak, SM; Retter, A; Sanderson, B; Zhang, J | 1 |
| Bóta, A; Cherpokova, D; Farkas, ÁZ; Farkas, VJ; Feller, T; Kellermayer, MZ; Kiss, B; Kolev, K; Komorowicz, E; Longstaff, C; Sorvillo, N; Szabó, L; Varjú, I; Wacha, A; Wagner, DD | 1 |
| Ajjan, RA; Ali, M; Ariëns, RAS; Bailey, MA; Baker, SR; Baranauskas, A; Cheah, LT; Connell, SD; Cubbon, RM; Duval, C; Feller, T; McPherson, HR; Naseem, KM; Philippou, H; Raslan, Z; Ridger, VC; Yuldasheva, NY | 1 |
| Altschul, D; Benton, J; Boehme, AK; Cheng, NT; Dardick, J; Esenwa, C; Fernandez-Torres, J; Flomenbaum, D; Frontera, J; Goldman, I; Holland, R; Ishida, K; Kirchoff-Torres, K; Labovitz, D; Lendaris, A; Liberman, AL; Lord, A; Lu, J; Luna, J; Mabie, P; Malaviya, A; Moncrieffe, K; Patel, N; Seiden, J; Snyder, T; Soetanto, A; Toma, A; Torres, J; Willey, J; Yaghi, S | 1 |
| Carlsgaard, P; Fareed, J; Finkler, E; Guler, N; Hopkinson, W; Hoppensteadt, D; Liles, J; Wanderling, C | 1 |
| Gudaityte, R; Kupcinskas, J; Kupcinskiene, K; Macas, A; Maleckas, A; Petereit, R; Trepenaitis, D | 1 |
| Fujimoto, N; Hasegawa, K; Hasegawa, M; Ito, M; Katayama, N; Matsumoto, T; Nakatani, K; Sudo, A; Wada, H; Wakabayashi, H; Yamada, N; Yamaguchi, T; Yamashita, Y | 1 |
| Goya, T; Kato, M; Kohjima, M; Mutsuki, T; Ohe, M; Satoh, T; Yamashita, S | 1 |
| Hudecek, J; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Sokol, J; Stasko, J; Zolkova, J | 1 |
| Chaubet, F; Collet, JP; Ghebouli, R; Jandrot-Perrus, M; Letourneur, D; Loyau, S; Maire, M; Michel, JB; Saboural, P | 1 |
| Fan, WL; Liu, BY; Liu, P; Liu, YY; Yin, X; Zhao, JH | 1 |
| Feng, C; Gao, L; Guo, X; Wang, Q; Wang, Z; Wu, Y; Xing, B; Xu, Z; Yang, Y; Zhang, F | 1 |
| Wolberg, AS | 1 |
| Arnold, N; Beutel, ME; Binder, H; Blankenberg, S; Eggebrecht, L; Göbel, S; Jünger, C; Lackner, KJ; Laubert-Reh, D; Münzel, T; Pfeiffer, N; Prochaska, JH; Schulz, A; Spronk, HM; Ten Cate, H; Wild, PS | 1 |
| Li, L; Long, Y; Xiang, Z; Xing, F | 1 |
| Meng, X; Wang, B; Wang, Y; Zheng, G | 1 |
| Guo, L; Qi, Y; Wei, N; Yang, H | 1 |
| Alvarez-Bollea, MA; Bastos, L; Guglielmone, HA; Jarchum, GD | 1 |
| Caldwell, SH; Greenberg, CS; O'Leary, JG; Patton, HM | 1 |
| Bresser, P; Gerdes, VE; Meijers, JC; Oduber, CE; van Beers, EJ; van der Horst, CM | 1 |
| Asanuma, K; Hasegawa, M; Matsumoto, T; Miyamoto, N; Ohishi, K; Shimokariya, Y; Sudo, A; Uchida, A; Wada, H; Wakabayashi, H; Yamada, N; Yoshida, K | 1 |
| Cragg, AH; Ehrenwald, E; Gits, CC; Skeik, N | 1 |
| Chernysh, IN; Crichlow, A; Cuker, A; Ischiropoulos, H; Lightfoot, RT; Martinez, MR; Mills, AM; Nagaswami, C; Weisel, JW | 1 |
| Absar, S; Ahsan, F; Kwon, YM | 1 |
| Cini, M; Cosmi, B; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
| Dorđević, V; Miljić, P; Nedeljkov-Jančić, R; Subota, V; Zuvela, M | 1 |
| Aleman, MM; Byrnes, JR; Walton, BL; Wolberg, AS | 1 |
| Ariëns, R; Bridge, KI; Philippou, H | 1 |
| Dresse, MF; Kalenga, M; Lombet, J; Pieltain, C; Rigo, V; Tribolet, S | 1 |
| Aleman, MM; Byrnes, JR; Degen, JL; Di Paola, J; Flick, MJ; Lam, WA; Mackman, N; Tran, R; Wang, JG; Wolberg, AS | 1 |
| Bauduer, F | 1 |
| Feit, J; Hincker, A; Sladen, RN; Wagener, G | 1 |
| Alhayek, R; Casini, A; de Moerloose, P; Kouteich, KL; Lebreton, A; Neerman-Arbez, M | 1 |
| Shchukin, SP | 1 |
| Byrnes, JR; Walton, BL; Wolberg, AS | 1 |
| Bevelacqua, V; Fenga, C; Guarneri, C; Libra, M; Malaponte, G; Polesel, J; Signorelli, SS; Taborelli, M; Umezawa, K | 1 |
| Dronkers, CE; Huisman, MV; Klok, FA; van der Hulle, T | 1 |
| Furukawa, K; Kagawa, S; Kato, A; Kuboki, S; Miyazaki, M; Ohtsuka, M; Okamura, D; Sakai, N; Shimizu, H; Suzuki, D; Takano, S; Takayashiki, T; Yoshitomi, H | 1 |
| DeRose, G; Dubois, L; Forbes, TL; Istl, A; Kribs, S; Lee, K; Mujoomdar, A; Power, AH; Wiseman, D | 1 |
| Ariëns, RAS; Bouman, AC; Cheung, YW; McPherson, H; Ten Cate, H; Ten Cate-Hoek, AJ; Ten Wolde, M | 1 |
| Gao, K; Huang, J; Li, L; Wang, H; Yang, Z; Zhang, J | 1 |
| Gao, X; Hu, C; Xiao, W; Yang, X; Zhao, H; Zhu, Y | 1 |
| Bode, C; Hehrlein, C; Hilgendorf, I; Koeck, T; Mischak, H; Peter, K; Reinöhl, J; Rivera, J; Sackmann, C; Schiffer, E; von Zur Mühlen, C; Zirlik, A; Zürbig, P | 1 |
| Alves, S; Bell, J; Cecil, T; Chandrakumaran, K; Coakes, J; Knight, J; Mohamed, F; Moran, B; Roy, A; Sargant, N; Simpson, S; Wilson, P | 1 |
| Dong, JY; Huang, W; Luo, MH; Yu, XF; Zhou, CY; Zhu, QH | 1 |
| Dai, J; Ding, Q; Hu, Y; Liang, Q; Lu, Y; Ouyang, Q; Wang, H; Wang, X; Wu, W; Wu, X; Xie, Y; Zhou, J | 1 |
| Cheng, ZH; Liu, C; Sun, SQ; Wang, Q; Wang, ZY | 1 |
| Bohacekova, M; Kaldararova, M; Remkova, A; Simkova, I; Valkovicova, T; Vesely, J | 1 |
| Hidaka, Y; Kawasaki, T; Suehisa, E; Toku, M | 1 |
| Marchioro, P; Monica, C; Radu, C; Rossetto, V; Salmaso, L; Simioni, P; Spiezia, L; Tognin, G | 1 |
| Borel Derlon, A; de Moerloose, P; Gandon-Laloum, S; Le Querrec, A; Neerman-Arbez, M; Robert-Ebadi, H | 1 |
| Aya, G; Chauleur, C; Cochery-Nouvellon, E; Gris, JC; Lissalde-Lavigne, G; Marès, P; Mercier, E; Mismetti, P | 1 |
| Jen, H; Shew, S | 1 |
| Janssen, HL; Jie, KS; Leebeek, FW; Pattynama, PM; Smalberg, JH; Spaander, MV; van Buuren, HR; van den Berg, B | 1 |
| Hernandez, I; Nowak-Göttl, U; Schulte, T; Seehafer, T; Stoll, M; Thedieck, S; Weiler, H | 1 |
| Cieśla-Dul, M; Gaweda, B; Rózańska, M; Sadowski, J; Wypasek, E | 1 |
| Blamey, SL; Burns, P; Carter, DC; Forbes, CD; Lowe, GD; McArdle, BM; Prentice, CR | 1 |
| Auger, JM; Berny, MA; Bock, PE; Cosemans, JM; Heemskerk, JW; McCarty, OJ; Munnix, IC; Panizzi, P; Schols, SE; Watson, SP | 1 |
| Hou, LH; Liu, XE; Wang, MF; Yang, LH; Yang, XL; Zhang, RJ | 1 |
| Raabe, RD | 1 |
| Baldwin, J; Deatrick, KB; Elfline, M; Henke, PK; Luke, CE; Miller, EM; Sood, V; Upchurch, GR; Wakefield, TW | 1 |
| Baldwin, JF; Deatrick, KB; Diaz, JA; Elfline, MA; Henke, PK; Hogaboam, C; Kunkel, SL; Luke, CE; Mitsuya, M; Sood, V; Upchurch, GR; Wakefield, TW | 1 |
| Asami, K; Hayashi, Y; Kaibara, M; Katsumoto, Y; Omori, S; Uchimura, I; Yasuda, A | 1 |
| Bedi, VS; Mishra, MN | 1 |
| Lord, ST | 1 |
| Georgiopoulos, I; Kritikos, E; Laopodis, V; Liasis, L; Ntourakis, D; Papadopoulou, E; Sergentanis, TN; Tzardis, P | 1 |
| Domagała, TB; Januszek, R; Karkowski, G; Kotula-Horowitz, K; Lelakowski, J; Musiał, J; Piekarz, J; Rydlewska, A | 1 |
| Bhogaraju, A; Brennan, S; Sarode, R; Shen, YM | 1 |
| Bembenek, JP; Czlonkowska, A; Karlinski, M; Kobayashi, A | 1 |
| Preuss, C; Stoll, M | 1 |
| Hasegawa, M; Matsumoto, T; Nobori, T; Noma, K; Shimokariya, Y; Sudo, A; Uchida, A; Wada, H; Wakabayashi, H; Yamada, N; Yoshida, K | 1 |
| Domagała, TB; Januszek, R; Kotula Horowitz, K; Lelakowski, J; Majewski, J; Małecka, B; Musiał, J; Rydlewska, A; Ząbek, A | 1 |
| Cieśla-Dul, M; Drążkiewicz, T; Sadowski, J; Undas, A | 1 |
| Brzoska, T; Buczko, W; Chlopicki, S; Fedorowicz, A; Grochal, E; Kramkowski, K; Leszczynska, A; Mann, B; Mogielnicki, A; Motterlini, R; Urano, T | 1 |
| Aispuru, GR; Barousse, AP; Cardone, AJ; Clavier, MM; Gilberto, DO | 1 |
| Ahluwalia, M; Bo, ZM; Guevara, E; Tun, NM; Villani, GM | 1 |
| Biesma, DH; Haas, FJ; Kluft, C; Laterveer, RH; Schutgens, RE | 1 |
| Chen, D; Dai, J; Gu, N; Jiang, Q; Shi, D; Wang, C; Xu, Z; Yang, F | 1 |
| Benn, M; Klovaite, J; Nordestgaard, BG; Tybjærg-Hansen, A | 1 |
| Burghardt, S; Giers, G; Handschel, J; Kübler, NR; Naujoks, C | 1 |
| Darwish Murad, S; de Maat, MP; García-Pagán, JC; Janssen, HL; Koehler, E; Leebeek, FW; Plessier, A; Primignani, M; Rijken, DC; Seijo, S; Smalberg, JH; Trebicka, J; Valla, DC | 1 |
| Abbate, R; Antonucci, E; Bani, D; Becatti, M; Cellai, AP; Cenci, C; Fiorillo, C; Grifoni, E; Lami, D; Mannini, L; Marcucci, R; Olimpieri, B; Poli, D; Prisco, D | 1 |
| Brennan, SO; Ho, LL; Zebeljan, D | 1 |
| van der Bom, JG | 1 |
| Cichocki, L; Forjanics, A; Gasser, R; Köppel, H; Pilger, E; Renner, W | 1 |
| Alt, E; Banyai, M; Banyai, S; Koppensteiner, R | 1 |
| De Staercke, C; Hooper, WC | 1 |
| Andersen, TO; Groot, PD; Hjeltnes, N; Iversen, PO; Mowinckel, MC; Sandset, PM | 1 |
| Aleksic, N; Cushman, M; Folsom, AR; Heckbert, SR; Rosamond, WD; Tracy, RP; Tsai, AW | 1 |
| Dmoszyńska, A; Furmanik, F; Piecuch, W; Sokołowska, B; Walter-Croneck, A | 1 |
| Abdollahi, M; Cushman, M; Rosendaal, FR | 1 |
| Blinov, M; Harrington, DJ; Harrington, P; Kapustin, S; Malefora, A; Mitchell, M; Papayan, L; Savidge, GF; Schmeleva, V | 1 |
| Bernardi, F; Coccheri, S; Ferraresi, P; Gemmati, D; Legnani, C; Lunghi, B; Marchetti, G; Palareti, G; Pinotti, M; Scapoli, C | 1 |
| Böhles, H; Jacobi, G; Kieslich, M; Lanfermann, H; Porto, L; Schwabe, D | 1 |
| Bavbek, N; Dagli, M; Kosar, A; Ozturk, M; Sengul, N | 1 |
| Anthony, JP; Borsa, JJ; Burkart, DJ; Thurlo, SR | 1 |
| Damico, LA; Fallon, JT; Himber, J; Kirchhofer, D; Nemerson, Y; Riederer, MA; Roux, S; Wohlgensinger, C | 1 |
| Dmoszyńska, A; Furmanik, F; Piecuch, W; Sokołowska, B | 1 |
| Kozawa, O; Matsuno, H; Matsuo, O; Okada, K; Ueshima, S | 1 |
| BOCCHETTI, G; LUCIFERO, A | 1 |
| Watzke, HH | 1 |
| HOBBS, JT | 1 |
| NANSON, EM; PALKO, PD | 2 |
| FEDORUK, SO; NANSON, EM; PALKO, PD | 1 |
| DAVIES, JW; HOBBS, JT | 1 |
| Bałszan-Kowalska, I; Bińczak-Kuleta, A; Chełstowski, K; Ciechanowicz, A; Falkowski, A; Jastrzebska, M | 1 |
| Franchini, M; Krampera, M; Veneri, D | 1 |
| Brueckner, S; Eleftheriadis, S; Reinke, U; Roth-Isigkeit, A; Schmucker, P; Siemens, HJ | 1 |
| Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Andersson, J; Bengtsson, AA; Ekdahl, KN; Elgue, G; Nilsson, B; Rönnblom, L; Sturfelt, G | 1 |
| Fijnheer, R; Probst, K; Rothova, A | 1 |
| Bastounis, E; Mirilas, P; Papalambros, E; Sigala, F; Travlou, A | 1 |
| Funai, EF; Hart, D; Kim, E; Lee, MJ; Popiolek, D; Roqué, H; Stephenson, C | 1 |
| Chen, M; Wu, XM; Yuan, JY; Yuan, XZ; Zhang, SS | 1 |
| Kajikawa, R; Koga, Y; Oh, J; Sakata, I; Shiokawa, Y; Takasugi, Y; Yamamoto, Y | 1 |
| Brummel-Ziedins, KE; Mann, KG; Undas, A | 1 |
| Aillaud, MF; di Minno, G; Eriksson, P; Hamsten, A; Hawe, E; Humphries, S; Juhan-Vague, I; Mannila, MN; Margaglione, M; Mussoni, L; Silveira, A; Tremoli, E; Yudkin, J | 1 |
| Korte, W; Lämmle, B; Waser, G; Wuillemin, WA | 1 |
| Camilleri, RS; Cohen, H | 1 |
| Aznar, J; Calvo, J; Contreras, MT; Corella, D; España, F; Ricart, JM; Todolí, J; Vaya, A | 1 |
| Rosendaal, FR; Vossen, CY | 1 |
| Frisbie, JH | 2 |
| Bossi, F; Bulla, R; Debeus, A; Durigutto, P; Fischetti, F; Macor, P; Meroni, P; Pellis, V; Sblattero, D; Tedesco, F; Ziller, F | 1 |
| Coffin, R; Droulle, C; Jacotot, T; Leroux, B; Potron, G; Roussel, B | 1 |
| Bertina, RM; de Visser, MC; Houwing-Duistermaat, JJ; Rosendaal, FR; Uitte de Willige, S; Vos, HL | 1 |
| Chang, CJ; Hsu, LA; Hsu, TS; Ko, YL; Lee, YS; Teng, MS; Tsai, CT; Wu, S | 1 |
| Brueck, M; Kramer, W; Rauber, K; Runde, T | 1 |
| Alonso, A; Díez, N; España, F; Hermida, J; Medina, P; Montes, R; Navarro, S | 1 |
| Funakoshi, T; Kitao, K; Maruo, T; Morita, H; Moriyama, T; Ohara, N; Yata, A | 1 |
| Berghold, A; Helwig, U; Schaub, S; Ziervogel, H | 1 |
| Crist, RA; Flanders, MM; Phansalkar, AR; Roberts, WL; Rodgers, GM | 1 |
| de Mazancourt, P; de Raucourt, E; Fischer, AM; Meyer, G | 1 |
| Dörner, T; Hoppe, B; Kiesewetter, H; Salama, A; Tolou, F | 1 |
| Aléssio, AM; Annichino-Bizzacchi, JM; de Pádua Mansur, A; Höehr, NF; Ozelo, MC; Siqueira, LH | 1 |
| Dirrigl, A; Eckstein, HH; Heider, P; Metz, S; Zimmermann, A | 1 |
| Jing, TY; Liu, ZM; Wu, JX; Zhao, XY; Zhao, ZY | 1 |
| Aun, R; Benabou, JE; Casella, IB; Presti, C; Puech-Leão, P | 1 |
| Ay, C; Dorda, W; Pabinger, I; Simanek, R; Tengler, T; Vormittag, R; Vukovich, T | 1 |
| Bertina, RM; De Visser, MC; Rietveld, IM; Uitte de Willige, S; Vos, HL | 1 |
| Bertina, RM; de Visser, MC; Houwing-Duistermaat, JJ; Rosendaal, FR; van Minkelen, R; Vos, HL | 1 |
| Grünbacher, G; Köppel, H; Marx-Neuhold, E; März, W; Pilger, E; Renner, W; Wascher, T; Weger, W | 1 |
| Cornell, A; Cushman, M; Folsom, AR; Polak, J; Tang, Z; Tsai, MY; Wang, L | 1 |
| Corella, D; España, F; Falcó, C; Ferrando, F; Mira, Y; Simó, M; Todolí, J; Vayá, A | 1 |
| Duner, E; Fabris, F; Lombardi, AM; Randi, ML; Ruzzon, E; Scandellari, R; Scapin, M; Tezza, F | 1 |
| Madoiwa, S; Mimuro, J; Miyata, M; Niwa, K; Ohmori, T; Sakata, Y; Sugo, T; Tei, C | 1 |
| Ames, M; Bramlage, P; Diehm, C; Hoffmanns, P; Hoffmanns, W; Lawall, H; Paar, WD; Pira, A; Rapp, U | 1 |
| Carbone, S; Griffiths, AB; Hague, WM; Williams, VK | 1 |
| Doggen, CJ; Pomp, ER; Rosendaal, FR | 1 |
| Darnige, L; Haberer, JP; Horellou, MH; Meyer, A; Obstler, C; Samama, CM; Szwebel, TA | 1 |
| Golubykh, VL; Maksimenko, AV; Tischenko, EG | 1 |
| Hara, A; Kyogashima, M; Onaya, J; Taketomi, T | 1 |
| Andriamampandry, MD; Cazenave, JP; Freund, M; Gachet, C; Leray, C | 1 |
| Abgrall, JF; Billon, S; Escoffre-Barbe, M; Ferec, C; Mercier, B | 1 |
| Bertina, RM; Eikenboom, JC; Kamphuisen, PW; Pablo, R; Rosendaal, FR; Sturk, A; Vos, HL | 1 |
| Brosstad, F; Kvernebo, K; Laerum, F; Roy, S; Sakariassen, KS | 1 |
| Ivashchuk, SI | 1 |
| Dempfle, CE | 1 |
| Heller, W; Scholpp, J; Schulze, HJ; Schwenzer, N; Wendel, HP | 1 |
| Grant, PJ; Lane, DA | 1 |
| Bertina, RM; Rosendaal, FR; van Tilburg, NH | 1 |
| Light, DR; Morser, J; Nagashima, M; Pagila, R; Verhallen, P; Wang, M; Werner, M; Zhao, L | 1 |
| Heilmann, L; Hommel, G; Nieman, F; von Tempelhoff, GF | 1 |
| Ariëns, RA; Carter, AM; Catto, AJ; Grant, PJ; Kohler, HP; Stickland, MH | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
| Austin, H; Dilley, A; Ellingsen, D; Evatt, B; Hooper, WC; Lally, C; Rawlins, P; Silva, V; Wenger, NK; Wideman, C | 1 |
| Bergelin, RO; Chandler, WC; Manzo, RA; Meissner, MH; Strandness, DE; Zierler, BK | 1 |
| Goldman, C; Gosselin, R; Lee, SJ; Nguyen, NT; Owings, JT; Pevec, WC; Wolfe, BM | 1 |
| Mannucci, PM; Tripodi, A | 1 |
| Hunt, BJ; Kelly, J; Lewis, RR; Rudd, A | 1 |
| Amorim, S; Arocha-Piñango, CL; Gil San Juan, AG; Guerrero, B; Müller, CA; Perales, J; Pinto, MA | 1 |
| Booth, NA; Mutch, NJ; Robbie, LA | 1 |
| Kerr, R; Ludlam, CA; Stirling, D | 1 |
| Blake, GJ; Lindpaintner, K; Ridker, PM; Schmitz, C | 1 |
| Arepally, A; Geschwind, JF; Hofmann, LV; Kim, HS; Kirkwood, S; Oechsle, D; Perler, B | 1 |
| Coccheri, S; Legnani, C; Lunghi, B; Palareti, G; Preda, L; Rossi, E | 1 |
| Aznar, J; Corella, D; Estellés, A; Ferrando, F; Martínez, M; Mira, Y; Vayá, A; Villa, P | 1 |
| Shao, M; Wang, J; Wang, M; Wang, Y | 1 |
| Gaffney, PJ; Mcevoy, FJ; Webbon, PM | 1 |
| Aznar, J; Contreras, M; Corella, D; España, F; Estelles, A; Ferrando, F; Mira, Y; Vayá, A | 1 |
23 review(s) available for fibrinogen and Venous Thrombosis
| Article | Year |
|---|---|
Risk factors for preoperative deep venous thrombosis in hip fracture patients: a meta-analysis.
Topics: Aged; C-Reactive Protein; Dementia; Female; Fibrinogen; Hip Fractures; Humans; Incidence; Retrospective Studies; Risk Factors; Venous Thrombosis | 2022 |
Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2022 |
Efficacy of traditional Chinese medicine combined with rivaroxaban in the treatment of lower extremity deep vein thrombosis: A meta-analysis.
Topics: C-Reactive Protein; Drugs, Chinese Herbal; Fibrinogen; Humans; Lower Extremity; Medicine, Chinese Traditional; Rivaroxaban; Venous Thrombosis | 2022 |
Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review.
Topics: Cerebral Hemorrhage; ChAdOx1 nCoV-19; Fibrinogen; Humans; Intracranial Thrombosis; Risk Factors; Vaccination; Venous Thrombosis | 2023 |
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial Infarction; Pulmonary Embolism; Stroke; Tranexamic Acid; Transfusion Reaction; Venous Thrombosis | 2023 |
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19.
Topics: Anticoagulants; Computed Tomography Angiography; COVID-19; Disease Management; Disseminated Intravascular Coagulation; Echocardiography; Extracorporeal Membrane Oxygenation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Partial Thromboplastin Time; Platelet Count; Point-of-Care Systems; Prothrombin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombophilia; Ultrasonography, Doppler, Duplex; Venous Thrombosis; Ventilation-Perfusion Scan | 2020 |
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea.
Topics: Acute Coronary Syndrome; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Fibrinolysis; Gene Expression Regulation; Humans; Hypoxia; Inflammation; Oxidative Stress; Platelet Activation; Platelet Aggregation; Sleep Apnea, Obstructive; Stroke; Venous Thrombosis | 2021 |
Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition.
Topics: Animals; Blood Coagulation; Erythrocytes; Factor VIII; Fibrinogen; Humans; Venous Thromboembolism; Venous Thrombosis | 2018 |
AGA Clinical Practice Update: Coagulation in Cirrhosis.
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Factor Xa Inhibitors; Fibrinogen; Hematocrit; Heparin; Humans; International Normalized Ratio; Liver Cirrhosis; Plasma; Platelet Count; Portal Vein; Thrombelastography; Thrombocytopenia; Thrombophilia; Thrombopoietin; Transfusion Reaction; Venous Thrombosis | 2019 |
Fibrinogen and red blood cells in venous thrombosis.
Topics: Animals; Blood Coagulation; Erythrocytes; Fibrinogen; Humans; Veins; Venous Thrombosis | 2014 |
Clot properties and cardiovascular disease.
Topics: Arterial Occlusive Diseases; Blood Coagulation; Cardiovascular Agents; Cardiovascular Diseases; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Porosity; Venous Thrombosis | 2014 |
Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
Topics: Animals; Blood Coagulation; Erythrocytes; Factor XIII; Fibrin; Fibrinogen; Humans; Protein Conformation; Signal Transduction; Structure-Activity Relationship; Venous Thrombosis | 2015 |
Current standings in diagnostic management of acute venous thromboembolism: Still rough around the edges.
Topics: Acute Disease; Clinical Decision-Making; Decision Support Techniques; Diagnostic Imaging; Disease Management; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis | 2016 |
Molecular mechanisms affecting fibrin structure and stability.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Protein Conformation; Structure-Activity Relationship; Venous Thrombosis | 2011 |
Inherited risk factors for thrombotic diseases in children: the genome-wide perspective.
Topics: Adult; Anticoagulants; Child; Drug Resistance; Factor V; Family; Fibrinogen; Genome-Wide Association Study; Humans; Infant, Newborn; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Risk Factors; Stroke; Thrombophilia; Venous Thrombosis | 2011 |
Venous thromboembolism: implications for gene-based diagnosis and technology development.
Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis | 2002 |
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis | 2003 |
Statins and blood coagulation.
Topics: Animals; Anticholesteremic Agents; Anticoagulants; Arteriosclerosis; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Factor VII; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Biological; Protein Prenylation; Protein Processing, Post-Translational; Staphylococcal Protein A; Thrombin; Thrombomodulin; Thrombophilia; Thromboplastin; Venous Thrombosis | 2005 |
The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Topics: Acute Disease; Animals; Blood Coagulation; Chronic Disease; Disseminated Intravascular Coagulation; Epitopes; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Thrombophilia; Venous Thrombosis | 1999 |
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
Topics: 3' Untranslated Regions; Arterial Occlusive Diseases; Blood Coagulation Factors; Factor V; Factor VII; Factor XIII; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Hemostasis; Humans; Hyperhomocysteinemia; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Point Mutation; Polymorphism, Genetic; Prothrombin; Receptors, Cell Surface; Risk Factors; Sequence Deletion; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2000 |
Laboratory investigation of thrombophilia.
Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis | 2001 |
Screening for subclinical deep-vein thrombosis.
Topics: Anticoagulants; Aspirin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Magnetic Resonance Imaging; Patient Selection; Plethysmography; Venous Thrombosis | 2001 |
Interleukin 6 and haemostasis.
Topics: Arteriosclerosis; Blood Coagulation Factors; Blood Platelets; Endothelium, Vascular; Factor VIII; Fibrinogen; Hemostasis; Hepatocytes; Humans; Interleukin-6; Leukocytes; Models, Biological; Receptors, Interleukin-6; Thromboplastin; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2001 |
9 trial(s) available for fibrinogen and Venous Thrombosis
| Article | Year |
|---|---|
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Biomarkers; Carboxypeptidase B2; Female; Fibrinogen; Humans; Male; Middle Aged; Thromboplastin; Venous Thrombosis | 2017 |
Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery.
Topics: Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genital Neoplasms, Female; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Laparoscopy; Middle Aged; Postoperative Complications; Prothrombin Time; Treatment Outcome; Venous Thrombosis; Young Adult | 2018 |
Deep venous thrombosis in acute stroke patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Sex Factors; Stroke; Time Factors; Venous Thrombosis | 2012 |
Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Factor Xa Inhibitors; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fondaparinux; Hemorrhage; Humans; Male; Middle Aged; Polysaccharides; Postoperative Complications; Venous Thrombosis | 2012 |
Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthesia, Spinal; Antithrombin III; Arthroplasty, Replacement, Hip; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Platelet Count; Postoperative Complications; Prothrombin; Prothrombin Time; Venous Thrombosis | 2003 |
[Incidence of deep venous thrombosis (DVT) in patients undergoing thoracotomy and changes of hemostasis].
Topics: Adult; Aged; Antithrombins; Esophageal Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; International Normalized Ratio; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen Inactivators; Prospective Studies; Prothrombin Time; Thoracotomy; Venous Thrombosis | 2004 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis.
Topics: Adult; Biomarkers; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Prothrombin; Sensitivity and Specificity; Thrombophlebitis; Venous Thrombosis | 2000 |
Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass.
Topics: Adult; Antithrombin III; Bandages; Blood Coagulation Factors; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gastric Bypass; Gravity Suits; Humans; Laparoscopy; Laparotomy; Male; Middle Aged; Peptide Hydrolases; Plasminogen; Protein C; Prothrombin; Venous Thrombosis | 2001 |
175 other study(ies) available for fibrinogen and Venous Thrombosis
| Article | Year |
|---|---|
Could a D-dimer/fibrinogen ratio have a role in ruling-out venous thromboembolism?
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Prospective Studies; Pulmonary Embolism; Retrospective Studies; Venous Thromboembolism; Venous Thrombosis | 2022 |
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.
Topics: Anticoagulants; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2022 |
MicroRNA-136-5p from Endothelial Progenitor Cells-released Extracellular Vesicles Mediates TXNIP to Promote the Dissolution of Deep Venous Thrombosis.
Topics: Animals; Antagomirs; Antithrombins; Carrier Proteins; Endothelial Progenitor Cells; Extracellular Vesicles; Fibrinogen; Fibrinolysin; Mice; MicroRNAs; Thioredoxins; Thrombin; Venous Thrombosis | 2022 |
Effect of Early Electroacupuncture Combined with Enhanced Recovery after Surgery (ERAS) on Pain Perception and Dysfunction in Patients after Total Knee Arthroplasty (TKA).
Topics: Arthroplasty, Replacement, Knee; Case-Control Studies; Electroacupuncture; Enhanced Recovery After Surgery; Fibrinogen; Humans; Knee Joint; Osteoarthritis, Knee; Pain; Pain Perception; Postoperative Complications; Range of Motion, Articular; Retrospective Studies; Treatment Outcome; Venous Thrombosis | 2022 |
Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis.
Topics: Child; Fibrinogen; Humans; Liver Diseases; Portal Vein; Venous Thrombosis | 2022 |
The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways.
Topics: Animals; Anticoagulants; Catechin; Eosine Yellowish-(YS); Fibrinogen; Hematoxylin; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Polyphenols; Proto-Oncogene Proteins c-akt; Rabbits; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tea; Thrombin; Vascular Endothelial Growth Factor A; Venous Thrombosis; Warfarin | 2022 |
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Autoantibodies; Fibrinogen; Humans; Immunoglobulin Isotypes; Immunoglobulin M; Peptides, Cyclic; Rheumatoid Factor; Venous Thromboembolism; Venous Thrombosis | 2023 |
The role of D-dimer and fibrinogen testing in catheter-directed thrombolysis with urokinase for deep venous thrombosis.
Topics: Catheters; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2023 |
Assessment of fibrinogen albumin ratio in patients with pregnancy-related cerebral venous thrombosis.
Topics: Cerebrovascular Disorders; Female; Fibrinogen; Humans; Intracranial Thrombosis; Pregnancy; Retrospective Studies; Risk Factors; Venous Thrombosis | 2023 |
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop).
Topics: Afibrinogenemia; Anticoagulants; Blood Coagulation Tests; Codon, Nonsense; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Middle Aged; Recurrence; Thrombelastography; Venous Thrombosis; Warfarin | 2020 |
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
Topics: Arterial Occlusive Diseases; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Decision Support Techniques; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Host-Pathogen Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Organ Dysfunction Scores; Pandemics; Platelet Count; Pneumonia, Viral; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Retrospective Studies; SARS-CoV-2; Thromboembolism; Venous Thrombosis | 2020 |
VTE in ICU Patients With COVID-19.
Topics: Adult; Aged; Anticoagulants; Betacoronavirus; C-Reactive Protein; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Enoxaparin; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Incidence; Intensive Care Units; L-Lactate Dehydrogenase; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prothrombin Time; Pulmonary Embolism; SARS-CoV-2; Severity of Illness Index; Ultrasonography; Venous Thromboembolism; Venous Thrombosis | 2020 |
The predictive value of plasminogen activator inhibitor-1, fibrinogen, and D-dimer for deep venous thrombosis following surgery for traumatic lower limb fracture.
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Plasminogen Activator Inhibitor 1; Retrospective Studies; Venous Thrombosis | 2020 |
A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis.
Topics: Animals; Fibrinogen; Hemostasis; Hemostatics; Venous Thrombosis; Zebrafish | 2020 |
Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.
Topics: Animals; Animals, Genetically Modified; Anthralin; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Hep G2 Cells; Hepatocytes; Humans; Integrin alpha2; Morpholinos; Mutation; Oligonucleotides, Antisense; Proteomics; Small Molecule Libraries; Tretinoin; Venous Thrombosis; Zebrafish; Zebrafish Proteins | 2021 |
Small Molecules: A Novel Approach to Alter Fibrinogen Production and Impact Venous Thrombosis.
Topics: Fibrinogen; Hemostatics; Humans; Venous Thrombosis | 2021 |
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders.
Topics: Animals; Base Sequence; Biomarkers; Blood Coagulation; Blood Platelets; Disease Models, Animal; Exons; Fibrinogen; Gene Editing; Gene Expression; Plasmids; Platelet Activation; RNA, Guide, Kinetoplastida; Sequence Deletion; Venous Thrombosis; Zebrafish | 2021 |
The predictive value of platelet to lymphocyte ratio and D-dimer to fibrinogen ratio combined with WELLS score on lower extremity deep vein thrombosis in young patients with cerebral hemorrhage.
Topics: Cerebral Hemorrhage; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Lymphocytes; Predictive Value of Tests; Retrospective Studies; ROC Curve; Venous Thrombosis | 2021 |
Changes of anti-β2 glycoprotein I antibody IgA/G/M, platelet aggregation rate, plasma fibrinogen and d-dimer in guiding venous thrombosis during pregnancy.
Topics: Adult; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulins; Platelet Aggregation; Platelet Function Tests; Pregnancy; Venous Thrombosis; Young Adult | 2021 |
A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation.
Topics: Adult; C-Reactive Protein; Computed Tomography Angiography; COVID-19; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Intracranial Hemorrhages; London; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; State Medicine; Tertiary Care Centers; Ultrasonography, Doppler; Venous Thromboembolism; Venous Thrombosis | 2021 |
Citrullinated Fibrinogen Renders Clots Mechanically Less Stable, but Lysis-Resistant.
Topics: Animals; Citrullination; Disease Models, Animal; Fibrinogen; Fibrinolysis; Humans; Male; Mice, Inbred C57BL; Microscopy, Atomic Force; Thrombelastography; Venous Thrombosis | 2021 |
Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
Topics: Animals; Blood Coagulation; Blood Platelets; Cross-Linking Reagents; Disease Models, Animal; Factor XIIIa; Fibrinogen; Mice, Inbred C57BL; Optical Imaging; Pulmonary Embolism; Vena Cava, Inferior; Venous Thrombosis | 2021 |
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cluster Analysis; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Inflammation; Interleukin-6; Ischemic Stroke; L-Lactate Dehydrogenase; Leukocyte Count; Logistic Models; Machine Learning; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Venous Thrombosis | 2021 |
Monitoring of Hypercoagulability by Thromboelastography in Bariatric Surgery.
Topics: Adult; Bariatric Surgery; Biomarkers; Blood Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Postoperative Period; Predictive Value of Tests; ROC Curve; Thrombelastography; Thrombophilia; Venous Thrombosis | 2017 |
The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE.
Topics: Aged; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Embolism; Venous Thrombosis | 2018 |
Portal Vein Thrombosis Repeatedly Observed in a Cirrhotic Patient with Antiphospholipid Antibody Syndrome.
Topics: Antiphospholipid Syndrome; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Tomography, X-Ray Computed; Venous Thrombosis | 2016 |
Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
Topics: Adult; Afibrinogenemia; Base Sequence; Blood Coagulation Tests; Family; Fibrinogen; Fibrinogens, Abnormal; Gene Expression; Hemorrhage; Homozygote; Humans; Male; Middle Aged; Models, Molecular; Mutation; Pedigree; Protein Structure, Secondary; Severity of Illness Index; Venous Thrombosis | 2017 |
Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic Events.
Topics: Amines; Animals; Carotid Arteries; Dipeptides; Disease Models, Animal; Fibrinogen; Fibrinolysis; Fucose; Glucose; Humans; Intravital Microscopy; Lysine; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Serum Albumin; Sulfates; Thrombelastography; Thrombosis; Tissue Plasminogen Activator; Venous Thrombosis | 2018 |
Preventive effects of low molecular weight heparin on formation of deep vein thrombosis by reducing D dimer values in patients undergoing spinal surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Leukocytes; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Venous Thrombosis | 2018 |
Coagulation Alteration and Deep Vein Thrombosis in Brain Tumor Patients During the Perioperative Period.
Topics: Adult; Aged; Biomarkers; Blood Coagulation; Brain Neoplasms; Craniotomy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Perioperative Period; Postoperative Complications; Thrombophilia; Venous Thrombosis | 2018 |
Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.
Topics: Adrenomedullin; Adult; Aged; Ankle Brachial Index; Anticoagulants; Asymptomatic Diseases; Atrial Fibrillation; Atrial Natriuretic Factor; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibrinogen; Germany; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenprocoumon; Protein Precursors; Pulmonary Embolism; Risk Factors; Stroke; Stroke Volume; Vascular Stiffness; Venous Thrombosis; Warfarin | 2018 |
Admission prevalence of deep vein thrombosis in elderly Chinese patients with hip fracture and a new predictor based on risk factors for thrombosis screening.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; China; Decision Support Techniques; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hip Fractures; Humans; Male; Middle Aged; Patient Admission; Phlebography; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Ultrasonography; Venous Thrombosis | 2018 |
The effects of VEGF on deep venous thrombosis in the perioperative period of elderly fracture patients.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fractures, Bone; Humans; Male; Perioperative Period; Thrombelastography; Time Factors; Vascular Endothelial Growth Factor A; Venous Thrombosis | 2018 |
Recurrent superficial venous thrombophlebitis because of mutations in the protein C and fibrinogen genes in a young Argentinian female.
Topics: Afibrinogenemia; Argentina; Female; Fibrinogen; Heterozygote; Humans; Mutation, Missense; Protein C; Recurrence; Sequence Analysis, DNA; Thrombophlebitis; Venous Thrombosis; Young Adult | 2019 |
Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Klippel-Trenaunay-Weber Syndrome; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Prothrombin; Pulmonary Embolism; Ultrasonography, Doppler, Duplex; Venous Thromboembolism; Venous Thrombosis; Young Adult | 2013 |
The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.
Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Anticoagulants; Arthroplasty, Replacement, Knee; Biomarkers; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fondaparinux; Hemoglobins; Humans; Male; Middle Aged; Polysaccharides; Risk Factors; Venous Thrombosis | 2013 |
Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Drug Monitoring; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lower Extremity; Male; Middle Aged; Minnesota; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Young Adult | 2013 |
Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
Topics: Adult; Aged; Blood Coagulation; Cross-Linking Reagents; Elasticity; Factor XIIIa; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Plasminogen; Prospective Studies; Pulmonary Embolism; Venous Thrombosis | 2014 |
Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis.
Topics: Animals; Fibrinogen; Fibrinolytic Agents; Peptides; Rats; Rats, Sprague-Dawley; Serum Albumin; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis | 2014 |
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units.
Topics: Age Factors; Aged; Aged, 80 and over; Biological Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Reference Values; Venous Thromboembolism; Venous Thrombosis | 2014 |
Coexistence of hypofibrinogenemia and factor V Leiden mutation: is the balance shifted to thrombosis?
Topics: Adult; Afibrinogenemia; Factor V; Fibrinogen; Heterozygote; Humans; Male; Point Mutation; Thrombophilia; Venous Thrombosis | 2014 |
[How I explore and treat a neonatal renal vein thrombosis: a case report].
Topics: Adult; Fibrinogen; Hematuria; Humans; Male; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Renal Veins; Thrombocytopenia; Ultrasonography, Doppler; Venous Thrombosis | 2014 |
Factor XIII activity mediates red blood cell retention in venous thrombi.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Erythrocytes; Factor XIII; Factor XIII Deficiency; Factor XIIIa; Fibrinogen; Homozygote; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mutant Proteins; Mutation; Peptide Fragments; Venous Thrombosis | 2014 |
Is there a significant lower genetic susceptibility to venous thrombosis in the Basques?
Topics: ABO Blood-Group System; Alleles; Ethnicity; Factor V; Factor XI; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Spain; Venous Thrombosis; von Willebrand Factor | 2014 |
Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery.
Topics: Adult; Aged; Female; Fibrinogen; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Predictive Value of Tests; Prospective Studies; ROC Curve; Surgical Procedures, Operative; Thrombelastography; Thromboembolism; Venous Thrombosis | 2014 |
Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis.
Topics: Adult; Afibrinogenemia; Female; Fibrinogen; Humans; Pregnancy; Venous Thrombosis | 2015 |
[Modern methods of diagnosis of thrombophylic states and complex treatment of patients with thrombotic complications of severe forms of varicose disease].
Topics: Anticoagulants; Factor V; Factor VII; Factor XII; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Integrin alpha2; Integrin beta3; Leg; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Varicose Veins; Venous Thrombosis | 2014 |
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; Monocytes; Neoplasms; NF-kappa B; Smoking; Thromboplastin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Venous Thrombosis | 2015 |
Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience.
Topics: Abdominal Pain; Anticoagulants; Bile; Female; Fever; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatectomy; Humans; Hyperammonemia; Incidence; Liver; Male; Middle Aged; Necrosis; Portal Vein; Retrospective Studies; Risk Factors; Splenectomy; Thrombectomy; Vena Cava, Inferior; Venous Thrombosis | 2015 |
Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Topics: Arterial Occlusive Diseases; Biomarkers; Catheterization, Peripheral; Down-Regulation; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Punctures; Retrospective Studies; Risk Assessment; Risk Factors; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2015 |
Clot structure and fibrinolytic potential in patients with post thrombotic syndrome.
Topics: Aged; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Postthrombotic Syndrome; Reproducibility of Results; Sensitivity and Specificity; Venous Thrombosis | 2016 |
[Analysis about the high risk factors and prognosis of gynecologic cancer with deep venous thrombosis].
Topics: Body Mass Index; China; Disease-Free Survival; Female; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Humans; Multivariate Analysis; Prognosis; Prothrombin Time; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2015 |
Impacts of laparoscopic hysterectomy on functions of coagulation and fibrinolysis system.
Topics: Adult; Blood Coagulation; Carboxypeptidase B2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hysterectomy; Laparoscopy; Middle Aged; P-Selectin; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Prothrombin Time; Retrospective Studies; Risk; Thrombin Time; Venous Thrombosis; von Willebrand Factor | 2016 |
Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism.
Topics: Adult; Aged; Animals; Biomarkers; Case-Control Studies; Collagen Type I; Electrophoresis, Capillary; Female; Fibrinogen; Gene Expression; Humans; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Middle Aged; Osteopontin; Proteome; Pulmonary Embolism; Sensitivity and Specificity; Support Vector Machine; Urinalysis; Venous Thrombosis | 2016 |
A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Blood Component Transfusion; Blood Loss, Surgical; Cytoreduction Surgical Procedures; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Tranexamic Acid; Venous Thrombosis | 2016 |
[Clinical significance of monitoring coagulation- and fibrinolysis-related indexes during catheter-directed thrombolysis for acute lower-extremity deep venous thrombosis].
Topics: Acute Disease; Blood Coagulation; Case-Control Studies; Catheters; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Thrombolytic Therapy; Treatment Outcome; Venous Thrombosis | 2016 |
Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
Topics: Afibrinogenemia; Antiphospholipid Syndrome; China; Fibrin; Fibrinogen; Humans; Male; Mutation; Venous Thrombosis; Young Adult | 2017 |
[Relationship of Serum D-dimer, Fibrinogen, C Reactive Protein and Interleukin 6 with Thrombus Dissolution Volume in Acute Iliac Femoral Vein Thrombosis Model Rats].
Topics: Acute Disease; Animals; Blood Coagulation; C-Reactive Protein; Femoral Vein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Interleukin-6; Rats; Solubility; Venous Thrombosis | 2016 |
Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?
Topics: Adult; Aged; Anticoagulants; Chronic Disease; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Platelet Count; Prevalence; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2016 |
Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Thrombin; Thrombomodulin; Venous Thrombosis | 2008 |
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis.
Topics: Acute Disease; Adult; Aged; Blood Coagulation; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Monitoring, Physiologic; Thrombelastography; Venous Thrombosis | 2008 |
A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Topics: Afibrinogenemia; Amino Acid Sequence; Amino Acid Substitution; Child, Preschool; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Mutation, Missense; Venous Thrombosis | 2008 |
Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort.
Topics: Adult; Cohort Studies; Erythrocyte Transfusion; Female; Fibrinogen; Hemostatics; Humans; Platelet Transfusion; Postpartum Hemorrhage; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis; Young Adult | 2008 |
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
Topics: Blood Component Transfusion; Critical Care; Critical Illness; Factor VIIa; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant; Male; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Venous Thrombosis | 2008 |
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
Topics: Adult; Budd-Chiari Syndrome; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Patient Selection; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Risk Assessment; Splanchnic Circulation; Thrombolytic Therapy; Treatment Outcome; Vascular Patency; Venous Thrombosis | 2008 |
Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Factor V; Family Health; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Infant; Male; Thromboembolism; Thrombosis; Venous Thrombosis | 2009 |
Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report.
Topics: Adult; Contraceptives, Oral; Factor V; Factor XIII; Female; Femoral Vein; Fibrinogen; Genetic Carrier Screening; Humans; Iliac Vein; Point Mutation; Polymorphism, Genetic; Ultrasonography; Venous Thrombosis | 2009 |
Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Anabolic Agents; Androgens; Biomarkers; Blood Viscosity; Case-Control Studies; Elective Surgical Procedures; Female; Fibrinogen; Fibrinolysis; Humans; Injections, Intramuscular; Liver Function Tests; Male; Middle Aged; Plasminogen; Plasminogen Activators; Postoperative Complications; Preoperative Care; Stanozolol; Time Factors; Venous Thrombosis | 1983 |
Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.
Topics: Animals; Blood Platelets; Calcium Signaling; Factor Xa; Fibrin; Fibrinogen; Humans; Mice; Perfusion; Phosphatidylserines; Platelet Aggregation; Protein Binding; Thrombin; Thromboplastin; Venous Thrombosis | 2010 |
[Correlation of inflammatory marker and coagulation factors with deep vein thrombosis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; C-Reactive Protein; Case-Control Studies; Factor IX; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Venous Thrombosis; Young Adult | 2010 |
Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Combined Modality Therapy; Down-Regulation; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Middle Aged; Peripheral Vascular Diseases; Radiography; Retrospective Studies; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonic Therapy; Vascular Patency; Venous Thrombosis; Washington; Young Adult | 2010 |
Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Topics: Animals; Collagen Type IV; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Interferon-gamma; Interleukin-1beta; Leukocytes; Ligation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator; Vena Cava, Inferior; Venous Thrombosis | 2010 |
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antithrombin III; Blood Coagulation; Calcium-Binding Proteins; Collagen; Cytokines; Disease Models, Animal; Fibrinogen; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myeloid Differentiation Factor 88; Neutrophils; Oligodeoxyribonucleotides; Peptide Hydrolases; Signal Transduction; Th1 Cells; Thrombelastography; Time Factors; Toll-Like Receptor 9; Venous Thrombosis | 2011 |
Dielectric coagulometry: a new approach to estimate venous thrombosis risk.
Topics: Animals; Blood Coagulation; Cattle; Dielectric Spectroscopy; Erythrocytes; Fibrinogen; Horses; Humans; Models, Theoretical; Rabbits; Rheology; Risk Factors; Thrombin; Venous Thrombosis | 2010 |
Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis.
Topics: Activated Protein C Resistance; Adult; Biomarkers; Epidemiologic Methods; Female; Fibrinogen; Humans; India; Male; Middle Aged; Popliteal Vein; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis; Young Adult | 2010 |
Subclinical activation of coagulation and fibrinolysis in laparoscopic cholecystectomy: do risk factors exist?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Cholecystectomy, Laparoscopic; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Postoperative Complications; Risk Factors; Sex Factors; Venous Thrombosis | 2011 |
[Venous thrombosis as a complication of pacemaker implantation--own observations].
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Pacemaker, Artificial; Plasminogen Activator Inhibitor 1; Prosthesis Implantation; Recurrence; Risk Factors; Smoking; Stroke Volume; Venous Thrombosis | 2011 |
Rare deletion from the fibrinogen Bβ gene in a patient with a provoked venous thrombotic event.
Topics: Adult; Afibrinogenemia; Chromatography, Reverse-Phase; DNA Mutational Analysis; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Phenotype; Sequence Deletion; Venous Thrombosis; White People | 2011 |
Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Incidence; Interleukin-6; Male; Middle Aged; Pacemaker, Artificial; Plasminogen Activator Inhibitor 1; Risk Factors; ROC Curve; Thromboplastin; Time Factors; Venous Thrombosis | 2012 |
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform.
Topics: Adult; Aged; Apoprotein(a); Female; Fibrin Clot Lysis Time; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Protein Isoforms; Reproducibility of Results; Sensitivity and Specificity; Venous Thrombosis | 2012 |
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Gas Analysis; Blood Platelets; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Green Fluorescent Proteins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Organometallic Compounds; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Solubility; Thrombosis; Time Factors; Venous Thrombosis; Water | 2012 |
Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure.
Topics: Aged; Aged, 80 and over; Anticoagulants; Biomarkers; Echocardiography; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Stroke Volume; Tissue Plasminogen Activator; Venous Thrombosis; Ventricular Function, Left | 2012 |
A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis.
Topics: Aged; Cerebral Hemorrhage; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Plasmapheresis; Platelet Count; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2012 |
Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; False Positive Reactions; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Proteolysis; ROC Curve; Venous Thrombosis | 2013 |
Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.
Topics: Animals; Blotting, Western; Disease Models, Animal; Drug Carriers; Endothelial Cells; Fibrinogen; Fibrinolytic Agents; Gene Expression Regulation; Iliac Vein; Immunohistochemistry; Injections, Intravenous; Ligation; Lipids; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microbubbles; Nitric Oxide; Nitric Oxide Synthase Type III; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thrombin Time; Thrombomodulin; Time Factors; Vascular Cell Adhesion Molecule-1; Vena Cava, Inferior; Venous Thrombosis | 2013 |
Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis.
Topics: Aged; Biomarkers; Denmark; Female; Fibrinogen; Humans; Male; Middle Aged; Odds Ratio; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2013 |
Parameters predicting complications in flap surgery.
Topics: Activated Protein C Resistance; Blood Coagulation Tests; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Forecasting; Free Tissue Flaps; Hematologic Tests; Hemorrhagic Disorders; Humans; Male; Necrosis; Plastic Surgery Procedures; Platelet Function Tests; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Reoperation; Skin Transplantation; Surgical Flaps; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2013 |
Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis.
Topics: Alleles; Case-Control Studies; Cohort Studies; Female; Fibrinogen; Fibrinogens, Abnormal; Genotype; Haplotypes; Humans; Liver Diseases; Male; Polymorphism, Single Nucleotide; Portal Vein; Venous Thrombosis | 2013 |
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Tests; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2013 |
Thrombosis in association with a novel substitution (γ346Gly→Val) at an absolutely conserved site in the fibrinogen γ chain.
Topics: Blood Coagulation; Blood Coagulation Tests; Conserved Sequence; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Mutation; Peptide Fragments; Phenotype; Venous Thrombosis; Young Adult | 2013 |
Does plasma fibrinogen increase thrombotic tendency?
Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk; Venous Thrombosis | 2002 |
G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis.
Topics: Alleles; Case-Control Studies; Fibrinogen; Genes, APC; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Polymorphism, Genetic; Risk Factors; Venous Thrombosis | 2002 |
Blood rheology in deep venous thrombosis--relation to persistent and transient risk factors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Viscosity; Case-Control Studies; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hematologic Tests; Hemorheology; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Time Factors; Venous Thrombosis | 2002 |
Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia.
Topics: Adult; Circadian Rhythm; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Plasminogen Activator Inhibitor 1; Quadriplegia; Risk Factors; Spinal Cord Injuries; Venous Thrombosis | 2002 |
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
Topics: Aged; Biomarkers; Blood Coagulation Factors; C-Reactive Protein; Cohort Studies; Confidence Intervals; Factor VII; Female; Fibrinogen; Humans; Inflammation Mediators; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thromboembolism; Venous Thrombosis; von Willebrand Factor | 2002 |
[Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
Topics: Aged; alpha-2-Antiplasmin; Antithrombins; Arthroplasty, Replacement, Hip; Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemodilution; Humans; Male; Middle Aged; Prothrombin; Thrombin; Thromboembolism; Time Factors; Venous Thrombosis | 2002 |
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.
Topics: Adolescent; Adult; Blood Coagulation Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Factor IX; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Obesity; Risk Factors; Venous Thrombosis | 2003 |
Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.
Topics: Adult; Arterial Occlusive Diseases; DNA Mutational Analysis; DNA Primers; Factor V; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Prothrombin; Thromboembolism; Venous Thrombosis | 2003 |
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster.
Topics: Adolescent; Adult; Aged; DNA; Factor V; Female; Fibrinogen; Genotype; Heterozygote; Humans; Male; Middle Aged; Mutation; Polymorphism, Genetic; Thrombophilia; Venous Thrombosis | 2003 |
Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antithrombin III; Asparaginase; Brain; Brain Diseases; Cerebral Hemorrhage; Child; Female; Fibrinogen; Headache; Humans; Magnetic Resonance Imaging; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures; Venous Thrombosis | 2003 |
Global fibrinolytic capacity in colorectal cancer: a new clue to occult fibrinolysis.
Topics: Aprotinin; Colonic Neoplasms; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Male; Postoperative Complications; Postoperative Period; Prothrombin Time; Rectal Neoplasms; Risk; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2003 |
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Disease-Free Survival; Drug Therapy, Combination; Eptifibatide; Female; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hematocrit; Hemoglobins; Hemorrhage; Humans; Iliac Artery; Iliac Vein; Lower Extremity; Male; Middle Aged; Missouri; Peptides; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Prospective Studies; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2003 |
Inhibition of tissue factor limits the growth of venous thrombus in the rabbit.
Topics: Animals; Antibodies, Monoclonal; Blood Vessel Prosthesis; Fibrinogen; Immunohistochemistry; Jugular Veins; Leukocytes; Naphthalenes; Piperidines; Rabbits; Thromboplastin; Venous Thrombosis | 2003 |
[Evaluation of selected parameters of blood coagulation and fibrinolysis system in patients undergoing total hip replacement surgery with normovolemic hemodilution procedure and standard enoxaparine prophylaxis].
Topics: Aged; alpha-2-Antiplasmin; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Blood Coagulation; Blood Coagulation Factors; Enoxaparin; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemodilution; Humans; Male; Middle Aged; Primary Prevention; Prothrombin; Thrombin; Thromboembolism; Time Factors; Venous Thrombosis | 2003 |
Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
Topics: Acute Disease; alpha-2-Antiplasmin; Animals; Bleeding Time; Fibrinogen; Jugular Veins; Lung; Mice; Mice, Transgenic; Pulmonary Embolism; Time Factors; Tissue Plasminogen Activator; Venous Thrombosis | 2003 |
[Significance of fibrinogen B and its role in postoperative venous thrombosis].
Topics: Coagulants; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thrombosis | 1953 |
External measurement of fibrinogen uptake in experimental venous thrombosis and other local pathological states.
Topics: Autoradiography; Coagulants; Fibrinogen; Humans; Iodine; Iodine Radioisotopes; Thrombosis; Venous Thrombosis | 1962 |
EARLY DETECTION OF DEEP VENOUS THROMBOSIS URING IODINE-131 TAGGED FIBRINOGEN.
Topics: Coagulants; Diagnosis; Dogs; Fibrinogen; Iodine; Iodine Isotopes; Radioisotopes; Research; Thrombophlebitis; Venous Thrombosis | 1963 |
EARLY DETECTION OF DEEP VENOUS THROMBOSIS DURING IODINE-131 TAGGED FIBRINOGEN.
Topics: Coagulants; Diagnosis; Dogs; Fibrinogen; Iodine; Iodine Isotopes; Radioisotopes; Research; Thrombophlebitis; Venous Thrombosis | 1963 |
THE EARLY DETECTION OF DEEP VENOUS THROMBOSIS USING I131-TAGGED HUMAN FIBRINOGEN.
Topics: Angiography; Dogs; Femoral Vein; Fibrinogen; Geriatrics; Humans; Iodine Isotopes; Radiometry; Research; Serum Albumin; Thrombophlebitis; Vascular Surgical Procedures; Venous Thrombosis | 1964 |
Detection of venous thrombosis with 131 I-labelled fibrinogen in the rabbit.
Topics: Animals; Fibrinogen; Rabbits; Radiometry; Thrombosis; Venous Thrombosis | 1960 |
[Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
Topics: Activated Protein C Resistance; DNA Primers; Factor V; Female; Fibrinogen; Humans; Male; Middle Aged; Point Mutation; Venous Thrombosis | 2003 |
Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes.
Topics: Adult; Fibrinogen; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Orthopedic Procedures; Venous Thrombosis; von Willebrand Diseases | 2003 |
High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly.
Topics: Adolescent; Adult; Age Factors; Aged; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Risk; Venous Thrombosis | 2003 |
Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; beta-Thromboglobulin; Factor XI; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Phosphorylation; Platelet Activation; Thrombosis; Venous Thrombosis | 2004 |
Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Topics: Activated Protein C Resistance; Adult; Antigens; Antithrombin III; Behcet Syndrome; Cross-Sectional Studies; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Protein C; Protein S; Ristocetin; Thrombophilia; Venous Thrombosis; von Willebrand Factor | 2004 |
P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Blood Platelets; Cohort Studies; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; P-Selectin; Platelet Factor 4; Prospective Studies; Thrombocytopenia; Thromboembolism; Vascular Diseases; Venous Thrombosis | 2004 |
Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies.
Topics: Afibrinogenemia; Factor VIII; Female; Fibrinogen; Humans; Kidney; Ovary; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Recurrence; Venous Thrombosis; von Willebrand Factor | 2004 |
Mesenteric venous thrombosis in a patient with congenital afibrinogenemia and diffuse peritonitis.
Topics: Adult; Afibrinogenemia; Fibrinogen; Humans; Male; Mesenteric Vascular Occlusion; Perioperative Care; Peritonitis; Venous Thrombosis | 2005 |
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
Topics: Aged; Alleles; Body Mass Index; Case-Control Studies; Environment; Europe; Exons; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Interleukin-6; Introns; Male; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Risk; Smoking; Time Factors; Venous Thrombosis | 2004 |
Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Venous Thrombosis | 2005 |
No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Genetic Testing; Humans; Male; Middle Aged; Polymorphism, Genetic; Pulmonary Embolism; Venous Thrombosis | 2005 |
Haemorheological alterations in Behçet's disease are not related to a tendency for venous thrombosis.
Topics: Adult; Behcet Syndrome; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Risk Factors; Venous Thrombosis | 2005 |
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Case-Control Studies; Cross-Linking Reagents; Factor XIII; Female; Fibrinogen; Gene Frequency; Heterozygote; Homozygote; Humans; Leucine; Male; Middle Aged; Mutation; Odds Ratio; Risk; Valine; Venous Thrombosis | 2005 |
An animal model for venous thrombosis and spontaneous pulmonary embolism.
Topics: Animals; Autoradiography; Blood Coagulation Factors; Body Weight; Disease Models, Animal; Dogs; Fibrinogen; Humans; Iodine Isotopes; Lung; Platelet Aggregation; Pulmonary Embolism; Radiography; Sodium Morrhuate; Staining and Labeling; Thromboembolism; Time Factors; Tissue Distribution; Venous Thrombosis | 2005 |
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Coagulation; Complement C3; Complement C5; Complement C9; Complement System Proteins; Endothelium, Vascular; Escherichia coli; Female; Fibrinogen; Glycoproteins; Humans; Immunoglobulin G; Inflammation; Lipopolysaccharides; Male; Microscopy, Fluorescence; Protein Structure, Tertiary; Rats; Rats, Wistar; Thrombosis; Time Factors; Venous Thrombosis | 2005 |
[Thrombosis of the renal veins in a premature infant. Treatment with heparin and urokinase].
Topics: Acute Disease; Anticoagulants; Combined Modality Therapy; Cyanosis; Dehydration; Diarrhea, Infantile; Dyspnea; Factor V; Factor VII; Factor X; Female; Fibrinogen; Follow-Up Studies; Heparin; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Peritoneal Dialysis; Plasminogen; Renal Veins; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 1976 |
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.
Topics: Adolescent; Adult; Aged; Base Sequence; Fibrinogen; Genetic Variation; Haplotypes; Humans; Middle Aged; Risk Factors; Venous Thrombosis | 2005 |
Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.
Topics: Adult; Aged; Alleles; Cell Line, Tumor; DNA Mutational Analysis; Female; Fibrinogen; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Luciferases; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Protein Subunits; Recombinant Fusion Proteins; Taiwan; Thromboembolism; Venous Thrombosis | 2006 |
[Fibrinogen-guided thrombolysis with urokinase of a portal and mesenterial venous thrombosis during an acute episode of ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Diarrhea; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Heparin; Humans; Magnetic Resonance Imaging; Mesenteric Veins; Portal Vein; Prednisolone; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2006 |
Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C.
Topics: Adult; Anticoagulants; Female; Fibrinogen; Humans; Male; Middle Aged; Protein C; Reference Values; Risk Factors; Venous Thrombosis | 2006 |
A late complication of thrombosis in internal jugular vein and subclavian vein in a pregnant woman with ovarian hyperstimulation syndrome.
Topics: Abortion, Induced; Adult; Anticoagulants; Antithrombin III; Embryo Transfer; Female; Fertilization in Vitro; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Jugular Veins; Ovarian Hyperstimulation Syndrome; Pleural Effusion; Pregnancy; Pregnancy Complications, Hematologic; Subclavian Vein; Venous Thrombosis; Warfarin | 2006 |
Coagulation parameters after retransfusion of unwashed blood.
Topics: Aged, 80 and over; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Blood Transfusion, Autologous; Estrogen Replacement Therapy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Filtration; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Retreatment; Time Factors; Venous Thrombosis | 2006 |
Pediatric reference intervals for uncommon bleeding and thrombotic disorders.
Topics: Adolescent; alpha-2-Antiplasmin; Antithrombins; Blood Coagulation Disorders; Child; Factor V; Factor VII; Factor X; Fibrinogen; Humans; Pediatrics; Plasminogen; Protein C; Protein S; Prothrombin; Reference Values; Venous Thrombosis | 2006 |
A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III).
Topics: Adult; Arginine; Cysteine; Fibrinogen; Heterozygote; Humans; Male; Mutation; Pedigree; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2006 |
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Humans; Integrin alpha2; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Serine Endopeptidases; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2006 |
Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis.
Topics: Adolescent; Adult; Aged; Antithrombins; Blood Coagulation; Case-Control Studies; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fibrinogen; Genotype; Hormone Replacement Therapy; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein C; Protein S; Venous Thrombosis | 2007 |
[Thrombosis of the inferior vena cava and the iliac and femoral veins in a 24-year old man].
Topics: Adult; Anticoagulants; Factor V; Femoral Vein; Fibrinogen; Heterozygote; Humans; Iliac Vein; Male; Mutation; Phenprocoumon; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex; Vena Cava, Inferior; Venous Thrombosis | 2007 |
[A component of earthworm fibrinolytic enzyme having higher thrombolytic activity than total components in vivo].
Topics: Amino Acid Sequence; Animals; Bleeding Time; Dogs; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Fibrinolytic Agents; Lethal Dose 50; Male; Mice; Molecular Sequence Data; Molecular Weight; Oligochaeta; Rats; Rats, Wistar; Sequence Analysis, Protein; Spectrophotometry, Infrared; Venous Thrombosis | 2006 |
Fibrinogen metabolism in patients with spinal cord injury.
Topics: Acute Disease; Adult; Case-Control Studies; Chronic Disease; Disease Progression; Fibrin; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Male; Middle Aged; Paralysis; Pulmonary Embolism; Risk Factors; Spinal Cord Injuries; Time Factors; Venous Thrombosis | 2006 |
Late results of catheter-directed recombinant tissue plasminogen activator fibrinolytic therapy of iliofemoral deep venous thrombosis.
Topics: Acute Disease; Adolescent; Adult; Catheterization, Peripheral; Epidemiologic Methods; Female; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Humans; Iliac Vein; Male; Middle Aged; Postphlebitic Syndrome; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency; Venous Thrombosis | 2007 |
Venous thromboembolism--a manifestation of the metabolic syndrome.
Topics: Adult; Aged; Austria; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cytokines; Factor VIII; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Prospective Studies; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophilia; Triglycerides; Venous Thrombosis; Waist-Hip Ratio | 2007 |
Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio.
Topics: Base Sequence; Cell Line; DNA Primers; Fibrinogen; Haplotypes; Humans; In Vitro Techniques; Mutagenesis, Site-Directed; Peptide Fragments; Polymorphism, Single Nucleotide; Recombinant Proteins; RNA Precursors; RNA Processing, Post-Transcriptional; RNA, Messenger; Sequence Deletion; Transcription, Genetic; Transfection; Venous Thrombosis | 2007 |
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Homozygote; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Introns; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Receptors, Interleukin-1 Type I; Receptors, Interleukin-1 Type II; Risk Assessment; Risk Factors; Venous Thrombosis | 2007 |
The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
Topics: Adult; Aged; Austria; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis | 2007 |
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Base Sequence; Deoxyribonucleases, Type II Site-Specific; DNA Primers; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Venous Thrombosis | 2007 |
Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
Topics: Adult; Blood Viscosity; Body Mass Index; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Triglycerides; Venous Thrombosis | 2007 |
Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders.
Topics: Adult; Case-Control Studies; DNA Mutational Analysis; Factor XII; Female; Fibrinogen; Hemostasis; Humans; Integrin beta3; Janus Kinase 2; Male; Philadelphia Chromosome; Polycythemia Vera; Polymorphism, Genetic; Risk Assessment; Risk Factors; Thrombocythemia, Essential; Venous Thrombosis | 2007 |
Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
Topics: Adult; Amino Acid Substitution; Calcium; Catalysis; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Humans; Ions; Microscopy, Electron, Scanning; Polymerase Chain Reaction; Postpartum Period; Solubility; Surface Properties; Thrombin; Thrombophilia; Time Factors; Tissue Plasminogen Activator; Venous Thrombosis | 2008 |
Prevalence of deep vein thrombosis (DVT) in non-surgical patients at hospital admission.
Topics: Aged; C-Reactive Protein; Dimerization; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospitalization; Humans; Male; Middle Aged; Prevalence; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Venous Thrombosis | 2007 |
Fibrinogen concentration and factor VIII activity in women with preeclampsia.
Topics: Abortion, Threatened; Cholestasis; Factor VIII; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Venous Thrombosis | 2007 |
Alcohol consumption is associated with a decreased risk of venous thrombosis.
Topics: Adult; Aged; Alcohol Drinking; Case-Control Studies; Down-Regulation; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Pulmonary Embolism; Risk Assessment; Risk Factors; Sex Factors; Surveys and Questionnaires; Venous Thrombosis; von Willebrand Factor | 2008 |
Postoperative deep venous thrombosis in a woman with congenital afibrinogenaemia treated with fibrinogen concentrates.
Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Eye Enucleation; Female; Fibrinogen; Humans; Postoperative Complications; Treatment Outcome; Ultrasonography; Venous Thrombosis | 2008 |
Thrombolytic effect after sequential double-bolus administration of tissue plasminogen activator and urokinase-fibrinogen conjugate into dogs with venous thrombosis.
Topics: Animals; Dogs; Drug Therapy, Combination; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Injections, Intravenous; Recombinant Proteins; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 1998 |
Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.
Topics: Animals; Blood Coagulation; Calcium Chloride; Disease Models, Animal; Factor XII; Fibrinogen; Gangliosides; Kinetics; Male; Protein Binding; Prothrombin Time; Rats; Rats, Sprague-Dawley; Sulfoglycosphingolipids; Venous Thrombosis | 1998 |
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis.
Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fibrinogen; Fibrinolytic Agents; Male; Platelet Count; Rats; Rats, Wistar; Thrombosis; Venous Thrombosis | 1999 |
Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients.
Topics: Factor V; Fibrinogen; Humans; Point Mutation; Risk Factors; Venous Thrombosis | 1999 |
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
Topics: Acute-Phase Reaction; Adult; Aged; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Venous Thrombosis | 1999 |
Selective venous thrombolysis with the nipple-balloon catheter: comparative evaluation in vivo.
Topics: Animals; Anticoagulants; Catheterization; Contrast Media; Coronary Vessels; Disease Models, Animal; Drug Delivery Systems; Equipment Design; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Heparin; Hindlimb; Iliac Vein; Iodine; Ioxaglic Acid; Partial Thromboplastin Time; Pulmonary Embolism; Spectrometry, X-Ray Emission; Swine; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis | 1999 |
[The influence of the intra-tissue electrical phonophoresis on the hemostasis system in the treatment of acute thrombophlebitis and phlebothrombosis].
Topics: Acute Disease; Adult; Blood Coagulation; Cell Adhesion Molecules; Electric Stimulation; Female; Fibrinogen; Homeostasis; Humans; Male; Middle Aged; Phonophoresis; Thrombophlebitis; Venous Thrombosis | 1999 |
Evaluation of markers of deep vein thrombosis in patients undergoing surgery for maxillofacial malignancies.
Topics: Antithrombin III; Blood Coagulation Tests; Case-Control Studies; Factor XIIa; Fibrinogen; Head and Neck Neoplasms; Humans; Kallikrein-Kinin System; Monitoring, Intraoperative; Multivariate Analysis; Peptide Hydrolases; Postoperative Complications; Thromboembolism; Tissue Plasminogen Activator; Venous Thrombosis | 1999 |
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.
Topics: Adult; Age Factors; Aged; Antithrombins; Biomarkers; Carboxypeptidase B2; Carboxypeptidases; Case-Control Studies; Contraceptives, Oral; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Protein C; Prothrombin; Reference Values; Regression Analysis; Venous Thrombosis | 2000 |
An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
Topics: alpha-2-Antiplasmin; Animals; Carboxypeptidase B2; Carboxypeptidases; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Drug Synergism; Endothelium, Vascular; Enzyme Activation; Fibrin; Fibrinogen; Fibrinolysis; Infusions, Intravenous; Plant Proteins; Plasminogen; Protease Inhibitors; Rabbits; Solanum tuberosum; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis | 2000 |
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Viscosity; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cohort Studies; Disease Progression; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Germany; Hematocrit; Hemorheology; Humans; Life Tables; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prospective Studies; Risk Factors; Survival Analysis; Thrombophilia; Uterine Cervical Neoplasms; Uterine Neoplasms; Venous Thrombosis | 2000 |
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
Topics: Fibrinogen; Humans; Polymorphism, Genetic; Venous Thrombosis | 2000 |
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Black People; Case-Control Studies; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Regression Analysis; Risk Factors; United States; Venous Thrombosis | 2000 |
Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model.
Topics: alpha-2-Antiplasmin; Animals; Anticoagulants; Arthropod Venoms; Disease Models, Animal; Factor XIII; Female; Fibrinogen; Fibrinolytic Agents; Infusions, Intravenous; Injections, Intravenous; Jugular Veins; Male; Plasminogen; Rabbits; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2001 |
Human thrombi contain an abundance of active thrombin.
Topics: Antithrombin III; Blotting, Western; Chromogenic Compounds; Dipeptides; Enzyme-Linked Immunosorbent Assay; Fibrin; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Prothrombin; Pulmonary Embolism; Thrombin; Venous Thrombosis | 2001 |
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Coronary Artery Disease; DNA Primers; Fibrinogen; Genotype; Germany; Humans; Male; Massachusetts; Middle Aged; Mutation; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Stroke; Venous Thrombosis; White People | 2001 |
Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Body Weight; Catheterization, Peripheral; Child; Child, Preschool; Fibrinogen; Graft Occlusion, Vascular; Hematocrit; Humans; Infant; Middle Aged; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2002 |
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Child; Drug Resistance; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Prothrombin; Recurrence; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
Biological risk factors for deep vein trombosis.
Topics: Biomarkers; Blood Glucose; Blood Viscosity; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Fibrinogen; Hematocrit; Humans; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; Venous Thrombosis | 2002 |
[Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
Topics: Animals; Endopeptidases; Female; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Male; Plasminogen; Rats; Rats, Wistar; Streptomyces; Venous Thrombosis | 1998 |
An experimental clot model in sheep; generation of a heterologous clot and its detection in vivo using venography and (125)I labelled fibrinogen.
Topics: Animals; Blood Coagulation; Cattle; Fibrinogen; Humans; Iodine Radioisotopes; Phlebography; Saphenous Vein; Sheep; Sheep Diseases; Venous Thrombosis | 2002 |
Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Risk Factors; Sex Factors; Triglycerides; Venous Thrombosis | 2002 |